The Senate scheduled a burst of confirmation hearings for the week of July 14, 2026, aiming to fill key national security, law enforcement, and public health positions that have sat vacant for months, some for more than a year. With the August recess approaching, Republican leadership faces a narrow window to move President Trump's picks for Director of National Intelligence, Attorney General, CDC Director, Labor Secretary, and Pentagon Comptroller through their respective committees.
The compressed timeline reflects a broader pattern: delayed nominations, internal Republican disagreements, and Democratic obstruction have left critical agencies running on acting officials well into the second year of Trump's term. The week's hearings amount to a stress test for a Senate majority that has sometimes struggled to move in lockstep with the White House.
Jay Clayton, the U.S. Attorney for the Southern District of New York, is Trump's pick to permanently lead the Office of the Director of National Intelligence. His confirmation hearing before the Senate Select Committee on Intelligence, chaired by Sen. Tom Cotton, is scheduled for Wednesday, but only after a false start that exposed friction between the White House and Capitol Hill.
Clayton was originally set to appear on June 17. That hearing never happened. Trump posted on Truth Social directing that Clayton's nomination should not move forward until Jamie McDonald was approved as the next SDNY attorney. Cotton, who had planned to proceed, confirmed the postponement in a statement on X.
"It's regrettable that the president has directed Jay Clayton not to appear at his confirmation hearing today," Cotton wrote on June 17. "Mr. Clayton is a patriot and a highly qualified nominee, as the president has said repeatedly. While today's hearing is now unfortunately postponed, I look forward to proceeding with his confirmation in the near future."
The delay carried real consequences. FISA Section 702, the provision allowing the government to collect and search American citizens' data without a warrant if they were in contact with targeted noncitizens located outside the U.S., expired on June 12. Without a confirmed DNI, the intelligence community's top civilian post remains in acting hands at a moment when surveillance authorities are lapsing and Senate Republicans have been wrestling with how to renew those powers.
The acting DNI, Bill Pulte, has drawn bipartisan criticism. Senate Minority Leader Chuck Schumer, asked by the Daily Caller News Foundation whether he supported Clayton, sidestepped the question and said he supported "getting rid of Pulte." That response, declining to engage with the actual nominee while taking a shot at the acting official, captures the evasive posture Democrats have adopted on several of these nominations.
Sen. John Thune offered a different assessment when asked about Clayton on June 11. "I think he's a really good pick," Thune told the DCNF. "He's obviously very capable and competent and [has] a great record. So, my assumption is, and I would certainly hope that Democrats who are being objective about it are going to come to the same conclusion."
Whether Democrats will be objective about it remains an open question. Three Republican senators previously sided with Democrats on an amendment to block Pulte from the acting intelligence role, a reminder that the GOP caucus itself has not always been unified on intelligence community appointments.
Todd Blanche, Trump's nominee for permanent Attorney General, is also scheduled to appear Wednesday. Blanche has been serving as acting AG since April 2, when Trump fired Pam Bondi. His path to the hearing has been complicated not by Democrats but by fellow Republicans.
Blanche spent 15 years at the Department of Justice in roles including contractor, paralegal in the Criminal Division, and at the U.S. Attorney's office for the Southern District of New York. Between 2023 and 2024, he served as Trump's defense attorney in three legal cases, a fact that has drawn scrutiny from senators concerned about DOJ independence.
Sen. Thom Tillis of North Carolina said in June he would not commit to supporting Blanche if there was any hint that the DOJ would not be independent from Trump's influence. Sen. John Cornyn of Texas posted on X on June 16 that he had "a positive interview" with Blanche but attached conditions.
"He committed to further briefing on the tax audit issue involving President Trump and his family. I will not make a decision on confirmation until..."
The post appeared truncated, but the message was clear enough: Cornyn wants answers before he votes yes.
The $1.8 billion anti-weaponization fund also loomed over Blanche's pre-hearing period. Senate Republicans engaged in what the Daily Caller News Foundation described as "heated conversations" with Blanche over the fund, which was included in the $69.5 billion reconciliation package Trump signed into law on June 10. Blanche testified before the House on June 2 that the DOJ had dropped the fund, an apparent effort to defuse the issue before his Senate hearing.
That Blanche faces more resistance from Republican senators than from Democrats tells you something about the state of play. The GOP majority wants to confirm a permanent AG, but it also wants guardrails, and Blanche will need to provide them under oath.
Erica Schwartz, the Deputy Surgeon General, is Trump's nominee to lead the Centers for Disease Control and Prevention. She is scheduled to appear before the Senate HELP Committee on Wednesday. If confirmed, she would end a leadership vacuum at the CDC that has stretched for nearly a year.
Trump fired CDC Director Susan Monarez in September after she refused to resign over clashes with HHS Secretary Robert F. Kennedy Jr. on vaccination policies. The agency has operated without a Senate-confirmed leader since. Trump's first pick for the post, Dr. David Weldon, withdrew his nomination in March 2025 after it became clear he would not garner enough votes in the HELP Committee, which raised questions about his past statements on vaccine safety.
Schwartz represents a reset. But the underlying tension between Kennedy's vaccine skepticism and the CDC's institutional role has not gone away. Senators on both sides of the aisle will likely press Schwartz on how she intends to navigate that divide, and whether she can maintain the agency's credibility while serving under an HHS secretary who has publicly clashed with the CDC's prior leadership.
The broader confirmation picture at health agencies reflects a pattern of turbulence. Republicans have been preparing for consequential personnel decisions across the government, but the pace of confirmed appointees has not kept up with the pace of departures.
Keith Sonderling, the acting Labor Secretary, is set to appear Thursday before the HELP Committee for his confirmation hearing. Trump appointed Sonderling to the acting role after Lori Chavez-DeRemer resigned on April 20 amid a monthlong internal investigation by the Labor Department's inspector general into allegations of misconduct, including workplace drinking and an affair with a subordinate.
Sonderling's hearing carries less drama than some of the others, but the Labor Department's recent instability makes the confirmation more urgent. An agency responsible for enforcing workplace regulations and managing labor data cannot afford indefinite acting leadership.
Jay Hurst, Trump's nominee for Pentagon Comptroller, opens the week with a Tuesday hearing before the Senate Armed Services Committee. Trump nominated Hurst in May. If confirmed, he would become the first Senate-confirmed Defense Department chief financial officer since Trump's second term began in January 2025, a gap of more than 18 months.
Hurst's hearing carries added weight because of the restart of Iran strikes on Tuesday, which broke a 60-day ceasefire that began in mid-June. Armed Services Committee members are expected to press Hurst on the overall cost of the Iran conflict, making his first public testimony a live-fire exercise in more ways than one.
Five major nominees. Four days. Three committees. The sheer volume of hearings scheduled for a single week underscores how far behind the Senate has fallen on confirmations. Some of these vacancies, the CDC directorship, the Pentagon CFO, have persisted for the better part of a year or longer. Others, like the AG and Labor Secretary slots, opened because of firings and resignations that created fresh gaps the Senate has been slow to fill.
The reasons vary. Trump himself delayed Clayton's hearing over a separate personnel dispute. Republican senators imposed conditions on Blanche that slowed his progress. Weldon's CDC nomination collapsed under bipartisan skepticism. Chavez-DeRemer's misconduct allegations forced an unplanned vacancy at Labor. Each delay had its own cause, but the cumulative effect is an executive branch running on acting officials at a moment when FISA authorities have lapsed, military operations are escalating, and political fights over legislation continue to consume Senate floor time.
Senate Republicans have the votes to confirm these nominees if they hold together. The question is whether the hearings this week produce enough answers, on DOJ independence, CDC autonomy, Pentagon spending, and intelligence oversight, to keep wavering members in line before the August recess closes the window.
Governing requires people in the chairs. The Senate has spent months leaving too many of them empty.